HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print September 2, 2003

This Article Full Text Full Text (PDF) All Versions of this Article: jlb.0203062v1 74/6/1064    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frleta, D. Articles by Wade, W. F. Search for Related Content PubMed PubMed Citation Articles by Frleta, D. Articles by Wade, W. F.

(Journal of Leukocyte Biology. 2003;74:1064-1073.)
© 2003 by Society for Leukocyte Biology

CD40-mediated up-regulation of Toll-like receptor 4-MD2 complex on the surface of murine dendritic cells

Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, New Hampshire

¹ Correspondence: Department of Microbiology and Immunology, 630W Borwell Building, Dartmouth Medical School, 1 Medical Center Drive, Lebanon, NH 03756. E-mail: William.F.Wade{at}Dartmouth.Edu

Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns, which are non-self macromolecular components of pathogens that allow the innate-immune system to recognize infection. TLRs are expressed on macrophages and dendritic cells (DC). TLR stimulation or CD40 agonists can induce inflammatory cytokine secretion from macrophages and DC, and promote DC maturation. The regulation of TLR expression by inflammation has begun to be explored. Our studies have focused on the regulation of TLR4 surface expression on DC. TLR4, along with the adaptor molecule MD2, is involved in the recognition of lipopolysaccharide (LPS). CD40 stimulation via cross-linked anti-CD40 monoclonal antibody (mAb) up-regulates TLR4-MD2 surface expression on a DC cell line (DC2.4) and on ex vivo-cultured splenic DC. LPS treatment down-regulated surface TLR4-MD2 on DC2.4 cells, but if combined with anti-CD40 mAb, increased TLR4-MD2 expression was observed. The increased TLR4-MD2 surface expression by any treatment did not correlate with TLR4 mRNA levels. The functional consequence of increased TLR4-MD2 expression following LPS and anti-CD40 treatment was examined. Although CD40 prestimulation did slightly enhance interleukin-12p70 secretion after LPS restimulation, simultaneous anti-CD40 mAb and LPS treatment, which up-regulates TLR4-MD2 complex, does not restore DC responsiveness to subsequent LPS.

Key Words: lipopolysaccharide • CD40 • toll-like receptors

This article has been cited by other articles:

				T. Kawasaki, M. A. Choudhry, M. G. Schwacha, S. Fujimi, J. A. Lederer, K. I. Bland, and I. H. Chaudry Trauma-hemorrhage inhibits splenic dendritic cell proinflammatory cytokine production via a mitogen-activated protein kinase process Am J Physiol Cell Physiol, March 1, 2008; 294(3): C754 - C764. [Abstract] [Full Text] [PDF]

				R. M Gorczynski, Y. Kai, and K. Miyake MD1 Expression Regulates Development of Regulatory T Cells J. Immunol., July 15, 2006; 177(2): 1078 - 1084. [Abstract] [Full Text] [PDF]

				J. A. Greene, J. L. DeVecchio, M. P. Gould, J. J. Auletta, and F. P. Heinzel In vivo and In vitro Regulation of Type I IFN Synthesis by Synergistic Effects of CD40 and Type II IFN J. Immunol., May 15, 2006; 176(10): 5995 - 6003. [Abstract] [Full Text] [PDF]